Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed/Refractory SCLC”

146 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 146 results

Testing effectiveness (Phase 2)Ended earlyNCT00283634
What this trial is testing

Tarceva for Use in Patients With Relapsed or Refractory Metastatic Non-Small Cell Lung Cancer

Who this might be right for
NSCLC
Millennium Pharmaceuticals, Inc.
Testing effectiveness (Phase 2)Ended earlyNCT05117242
What this trial is testing

Safety and Efficacy Study of GEN1046 as a Single Agent or in Combination With Pembrolizumab for Treatment of Recurrent (Non-small Cell) Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer Metastatic
Genmab 125
Testing effectiveness (Phase 2)Study completedNCT00101413
What this trial is testing

BAY43-9006 - Phase II Study in Non-Small Cell Lung Carcinoma (NSCLC)

Who this might be right for
CancerCarcinoma, Non-Small Cell Lung
Bayer 52
Testing effectiveness (Phase 2)Ended earlyNCT02963610
What this trial is testing

Phase I/II Study of Lenalidomide Plus Pembrolizumab in Patients With Solid Tumors With Expansion in Non-small Cell Lung Cancer

Who this might be right for
Relapsed or Refractory Solid TumorsNonsmall Cell Lung Cancer
Fox Chase Cancer Center 3
Large-scale testing (Phase 3)UnknownNCT00465491
What this trial is testing

Study of Picoplatin Efficacy After Relapse

Who this might be right for
Small Cell Lung Cancer
Poniard Pharmaceuticals 399
Testing effectiveness (Phase 2)Ended earlyNCT01266018
What this trial is testing

Study of ADI-PEG 20 in Patients With Relapsed Sensitive or Refractory Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
Ludwig Institute for Cancer Research 22
Early research (Phase 1)Active Not RecruitingNCT04503278
What this trial is testing

A Clinical Study of the Safety and Effectiveness of an Investigational Cell Therapy Given With and Without an Investigational RNA-based Vaccine in Patients With Organ Tumors

Who this might be right for
Solid Tumor
BioNTech Cell & Gene Therapies GmbH 214
Early research (Phase 1)Ended earlyNCT02034123
What this trial is testing

Investigation of GSK2879552 in Subjects With Relapsed/Refractory Small Cell Lung Carcinoma

Who this might be right for
Carcinoma, Small Cell
GlaxoSmithKline 29
Early research (Phase 1)Study completedNCT00441337
What this trial is testing

MDX-1106 in Patients With Selected Refractory or Relapsed Malignancies

Who this might be right for
Carcinoma, Non-Small-Cell LungColorectal CancerMalignant Melanoma+2 more
Bristol-Myers Squibb 39
Early research (Phase 1)Looking for participantsNCT04777994
What this trial is testing

Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors

Who this might be right for
Advanced Solid Tumor Cancer
Calico Life Sciences LLC 248
Early research (Phase 1)Study completedNCT02595866
What this trial is testing

Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer

Who this might be right for
AIDS-Related Non-Hodgkin LymphomaClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+16 more
National Cancer Institute (NCI) 58
Testing effectiveness (Phase 2)Ended earlyNCT02403895
What this trial is testing

AZD2014 and Weekly Paclitaxel in Squamous NSCLC

Who this might be right for
Squamous Non Small Cell Lung Cancer
AstraZeneca 11
Testing effectiveness (Phase 2)Study completedNCT02200757
What this trial is testing

Efficacy and Safety of Aldoxorubicin Compared to Topotecan in Subjects With Metastatic Small Cell Lung Cancer

Who this might be right for
Metastatic Small Cell Lung Cancer
ImmunityBio, Inc. 135
Testing effectiveness (Phase 2)UnknownNCT05975944
What this trial is testing

Study of Selinexor Combined With Olaparib in Relapsed/Refractory Extensive Stage Small Cell Lung Cancer

Who this might be right for
Extensive-stage Small Cell Lung Cancer
Tianjin Medical University Cancer Institute and Hospital 49
Early research (Phase 1)Study completedNCT00346385
What this trial is testing

BB-10901 in Treating Patients With Relapsed or Refractory Solid Tumors

Who this might be right for
Ovarian CancerMerkel Cell CarcinomaSCLC
ImmunoGen, Inc. 97
Large-scale testing (Phase 3)Study completedNCT03098030
What this trial is testing

Dinutuximab and Irinotecan Versus Irinotecan to Treat Subjects With Relapsed or Refractory Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
United Therapeutics 483
Testing effectiveness (Phase 2)Looking for participantsNCT05669846
What this trial is testing

Study of Healthy Donor FMT (hdFMT) and Pembrolizumab in Relapsed/Refractory (R/R) PD-L1 Positive NSCLC

Who this might be right for
Non Small Cell Lung Cancer
Diwakar Davar 26
Testing effectiveness (Phase 2)Study completedNCT00116610
What this trial is testing

Picoplatin as Second-Line Therapy for Patients With Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
Poniard Pharmaceuticals 75
Testing effectiveness (Phase 2)Study completedNCT00003281
What this trial is testing

Topotecan and Paclitaxel in Treating Patients With Recurrent or Refractory Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 84
Testing effectiveness (Phase 2)Ended earlyNCT05420636
What this trial is testing

Iadademstat in Combination With Paclitaxel in Relapsed/Refractory SCLC and Extrapulmonary High Grade NET

Who this might be right for
Small-cell Lung CancerNeuroendocrine Carcinoma
Fox Chase Cancer Center 20
Next Page